Beyond Digital Batch Records: Managing FDA and EU GMP Documentation While Preserving Data Integrity

How the use of digital/electronic versions of US FDA's and EU's DHF, DMR, DHR, and the EU's MDR Technical Documents Files / equivalents can reduce the possibility of delays in implementation/changes and chances of human error in use, while maintaining data integrity. A popular seminar, updated with the latest FDA and EU requirements and newer digital/electronic tools. As U.S. companies go global, they must meet different product design documentation. The cGMP's mandate Design Control and the Design History File (DHF). ISO 13485 mandates the same, a Design and Development File, per 7.3, which is now to be part of the EU's MDR-required documentation. In order to sell globally, the EU's CE-marking documentation is a requirement — the Technical Documentation File. Currently they serve different purposes, support different goals, but their roles do overlap. And how/where do the DMF and Batch Records fit? Newer incorporation of digital formats in lieu of the old paper/legacy systems has the promise of increasing documentation accuracy and data integrity, through implementation, updates/revision, changes, and even decommissioning. Regulatory accuracy, compliance and consistency is better assured as well. WHY YOU SHOULD ATTEND This seminar will examine the existing requirements for the US FDA's DHF, and the derivative documents, the DMR/F and DHR/batch records, the pros (and some cases cons) of digital/electronic alternatives, and the identical ISO 13485 7.3 D&DF. It will consider the EU's revised MDR and its Technical Documentation File requirements, and evaluate the documents' differing purposes/goals. Required and desirable contents will be discussed. Also considered: areas requiring frequent re-evaluation/update; similarities and differences; future trends; typical DHF Table of Contents; Technical Document File Table of Contents; the importance and usefulness of the old "Essential Requirements," now "General Safety and Performance Requirements," and a suggested matrix format; structure of the "Declaration of Conformity"; self-declaring or NB reviewed. Additional benefits from digital records include: simplifying version control; streamlining template review and approval; improving data accuracy; increasing accessibility; and the easy ability to scale. Finally, the differing approaches to file inspections/audits by the FDA and Notified Bodies will be discussed. Code: MD3752